ArticleAmerican health & drug benefits2016

Darzalex (Daratumumab): First Anti-CD38 Monoclonal Antibody Approved for Patients with Relapsed Multiple Myeloma.

Lisa A RaedlerPubMed ↗Full text ↗

No numbers read from the abstract.